Presence of conduct disorder affects antipsychotic treatment outcome in patients with schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 3, doi. 10.1002/pu.30716
- Publication type:
- Article
Works matching IS 10685308 AND DT 2021 AND VI 32 AND IP 5
Results: 12
1
2
Polypharmacy in clozapine‐treated patients.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 2, doi. 10.1002/pu.30715
- By:
- Publication type:
- Article
3
No evidence of benefit from citalopram in treatment of bipolar depression.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 1, doi. 10.1002/pu.30714
- Publication type:
- Article
4
The ghost of Heisenberg, or: methamphetamine, again.
- Published in:
- 2021
- By:
- Publication type:
- Film/TV Criticism and Review
5
Long‐acting injectable paliperidone shows greater benefit in early‐stage schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 4, doi. 10.1002/pu.30717
- Publication type:
- Article
6
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 9, doi. 10.1002/pu.30724
- Publication type:
- Article
7
Antipsychotics lower hospitalization risk in patients with delusional disorder.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 8, doi. 10.1002/pu.30723
- Publication type:
- Article
8
SNRIs demonstrate small benefit for back pain, osteoarthritis.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 8, doi. 10.1002/pu.30722
- Publication type:
- Article
9
Guideline on smoking cessation recommends varenicline for initiation.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 8, doi. 10.1002/pu.30721
- Publication type:
- Article
10
Other antipsychotics compare favorably to olanzapine on metabolic outcomes.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 6, doi. 10.1002/pu.30720
- Publication type:
- Article
11
No significant improvement from adjunctive aspirin in schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 6, doi. 10.1002/pu.30719
- Publication type:
- Article
12
Bupropion plus naltrexone shows some benefit in stimulant use disorder.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 1, doi. 10.1002/pu.30713
- Publication type:
- Article